Q1 FY27 snapshot
Announcement Date6-Aug-26
Revenue (Top Line)₹434.51 Cr
Net Profit (Bottom Line)₹-24.12 Cr
Earnings Per Share (EPS)₹0.63
Expenses₹421 Cr
Net profit margin (calculated)-5.6%
Cohance Lifesciences Ltd. (COHANCE) Quarterly Results: Q1 FY27
Quick answer: Cohance Lifesciences Ltd. (NSE: COHANCE) reported Q1 FY27 revenue of ₹434.51 Cr and net profit of ₹-24.12 Cr, with earnings per share (EPS) of ₹0.63, announced on 6-Aug-26.
That works out to a net profit margin of about -5.6% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Cohance Lifesciences Ltd.'s Q1 FY27 results
Revenue of ₹434.51 Cr is what Cohance Lifesciences Ltd. earned before costs. Net profit of ₹-24.12 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about -5.6%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Cohance Lifesciences Ltd. results FAQs
What were Cohance Lifesciences Ltd.'s Q1 FY27 results?
Cohance Lifesciences Ltd. (NSE: COHANCE) reported Q1 FY27 revenue of ₹434.51 Cr and net profit of ₹-24.12 Cr, with earnings per share (EPS) of ₹0.63, announced on 6-Aug-26.
What is Cohance Lifesciences Ltd.'s EPS for Q1 FY27?
Cohance Lifesciences Ltd.'s earnings per share for Q1 FY27 was ₹0.63. EPS is net profit divided by the number of outstanding shares.
When did Cohance Lifesciences Ltd. announce its Q1 FY27 results?
Cohance Lifesciences Ltd. announced its Q1 FY27 results on 6-Aug-26.
What is Cohance Lifesciences Ltd.'s net profit margin?
On the reported figures, Cohance Lifesciences Ltd.'s Q1 FY27 net profit margin is about -5.6% (net profit ÷ revenue).